NRIX SG&A Expense Growth
Nurix Therapeutics Inc · SG&A Expense Growth
NRIX SG&A Expense Growth
Latest reported14.80%period ending
NRIX FY SG&A Growth (YoY) (0.00% → 14.80%)
Latest values, visible window
High-resolution chart · PNG
NRIX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 14.7985% | |
| 7.0906% | |
| 12.9089% | |
| 21.7775% | |
| 91.3177% | |
| 95.8804% | |
| 24.7528% | |
| 0% |